Genomic Selection Articles & Analysis
13 news found
However, genome engineering is a slow, inefficient, and arduous process that limits microbial producers. ...
CD Genomics is a world-leading genomics services company, innovating in sequencing services for the genomics industry as well as genotyping, library construction, bioinformatics, aptamers, microarrays, health diagnostics, mutagenesis analysis, and more. ...
QN-302 (previously known as SOP1812) is the Company’s genomic quadruplex (G4)-selective transcription inhibitor platform being developed as a potential treatment for pancreatic ductal adenocarcinoma (PDAC), in addition to other tumors of high unmet clinical need. ...
Professor Neidle is a world-renowned scientist at University College London and is the key innovator of the Company’s in-licensed genomic quadruplex (G4)-selective transcription inhibitor platform. Qualigen is developing this platform’s lead compound, now called QN-302, as a potential treatment for pancreatic ductal adenocarcinoma (PDAC), which ...
(Nasdaq: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, today announces the exclusive worldwide in-license of a genomic quadruplex (G4)-selective transcription inhibitor drug development program, including lead and back-up compounds, preclinical data and a patent estate, ...
This information will complement genomics-only approaches and help oncologists select treatments.” About PARIS® Test The PARIS® Test is a next generation diagnostic test that predicts drug responses integrating knowledge of cancer genomics with drug sensitivity testing of patient-derived live cells combined with robotics and ...
LC-SCRUM-Asia, a leading cancer genomic screening program, has selected Thermo Fisher Scientific's Ion Torrent Genexus System* and Oncomine Precision Assay*, a pan-cancer panel, to advance precision medicine in Asia. ...
These highly influential DNA markers, in combination with thousands of markers that have a small effect, would allow efficient improvements through genomic selection. This is not the first time genomic selection has been used to strengthen disease resistance. Troutlodge was the first to use genomic ...
In order to bring them together in a cow in the best and fastest way possible, genomic selection is important for breeding organisations such as CRV, and by means of genome analysis we want to improve this further", says Veerkamp. Bull genome The genome of a bull consists of 3 billion ‘letters’. ...
Speed of analysis is particularly important in this high-throughput environment." CLG selected Agilent's genome-wide CGH+SNP microarrays for their capability, in a predictable high-throughput environment, to detect amplifications, deletions and cell line clonality with high sensitivity. ...
"After years of intense study, we are proud to join with Baylor-a global leader in cancer and cytogenetics research-to provide researchers with these powerful new tools for disease research," said Jacob Thaysen, vice president and general manager for Agilent's Diagnostics and Genomics business. Agilent manufactures a broad selection of microarrays for ...
The molecular breeding laboratory is also developing innovative genomic selection methods which incorporate genome-wide DNA marker information in a training population which enables accurate prediction of breeding gain. Through genomic selection, SGB will shorten the breeding cycle and significantly increase the ...
(NYSE: A) today announced it is expanding its life sciences business with two strategic acquisitions. Halo Genomics, a provider of innovative technology for the rapidly growing next-generation DNA sequencing market, has now joined Agilent. ...